Predictors of Recurrence in Patients with High-Risk Pathology after Prostatectomy
David C. Moore(United States Air Force Research Laboratory), Sam S. Chang(Vanderbilt University), S. Duke Herrell(Vanderbilt University Medical Center), Giovanna A. Giannico(Henry Ford Health System), Daniel A. Barocas(Vanderbilt University Medical Center), Chirag Kulahalli(Vanderbilt University), Chaochen You(Vanderbilt University Medical Center), Peter E. Clark(Levine Cancer Institute), Joseph A. Smith(King's College London), Rodney Davis(The University of Texas MD Anderson Cancer Center), Matthew J. Resnick(Vanderbilt University Medical Center), Michael S. Cookson(University of Oklahoma Health Sciences Center)
Cited by 1
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845